<scp> <i>RAB32</i> </scp> ‐Linked Parkinson's Disease: Deep Phenotyping, <scp>MDSGene</scp> Literature Review, and Application of <scp>SynNeurGe</scp> Criteria

While PARK-RAB32 is clinically and likely pathologically similar to idiopathic PD, our study underscores the importance of carefully assessing non-motor symptoms in this newly described form of PD. According to SynNeurGe criteria, PARK-RAB32 is classified as S<sup>+</sup> (evidence of synucleinopathy), N<sup>+</sup> (neurodegeneration supported by imaging data), and G<sub>P</sub> <sup>+</sup> (presence of a genetic variant). © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Authors

Institutions

Publication Details

Journal
Movement Disorders
Published
2025-10-17
DOI
https://doi.org/10.1002/mds.70037
Citations
1
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

RAB32 ‐Linked Parkinson's Disease: Deep Phenotyping, MDSGene Literature Review, and Application of SynNeurGe Criteria

Giulia Toschi, Katja Lohmann, Joanne Trinh, Francesco Cavallieri et al.
1 citations
Movement Disorders
Parkinson's Disease Mechanisms and Treatments
1.39
article

RAB32 ‐Linked Parkinson's Disease: Deep Phenotyping, MDSGene Literature Review, and Application of SynNeurGe Criteria

Giulia Toschi, Katja Lohmann, Joanne Trinh, Francesco Cavallieri, Simone Zittel, Letizia Santinelli, Franco Valzania, Carolin Gabbert, Michele Matarazzo, Teresa Kleinz, Edoardo Monfrini, Max Borsche, Max Brand, Valentina Fioravanti, Cholpon Shambetova, Mandy Radefeldt, Alessio Di Fonzo, Enza Maria Valente, Cornelis Blauwendraat, Norbert Brüggemann, Peter O. Bauer, Christian Beetz, Micol Avenali, Pierfrancesco Mitrotti, Rommi Born, Norman Griebner
article en
1 citations

Abstract

While PARK-RAB32 is clinically and likely pathologically similar to idiopathic PD, our study underscores the importance of carefully assessing non-motor symptoms in this newly described form of PD. According to SynNeurGe criteria, PARK-RAB32 is classified as S<sup>+</sup> (evidence of synucleinopathy), N<sup>+</sup> (neurodegeneration supported by imaging data), and G<sub>P</sub> <sup>+</sup> (presence of a genetic variant). © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Movement DisordersVol. 40(12)
National Institutes of Health (US), Universität Hamburg (DE), University of Milan (IT), University of Pavia (IT), Foundation Center (US), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Ospedale Maggiore (IT), Azienda Sanitaria Unità Locale di Reggio Emilia (IT), Klinikum Hanau (DE), Urology Foundation (GB), University Medical Center Hamburg-Eppendorf (DE), National Institute of Neurological Disorders and Stroke (US), University Hospital Schleswig-Holstein (DE), HM Hospitales (ES), National Institute on Aging (US), Centogene (Germany) (DE), Istituti di Ricovero e Cura a Carattere Scientifico (IT), University of Lübeck (DE)
Michael J. Fox Foundation for Parkinson's Research, EU Joint Programme – Neurodegenerative Disease Research, Deutsche Forschungsgemeinschaft, Else Kröner-Fresenius-Stiftung, National Institutes of Health
Openalex Percentile: Top 15%
Parkinson's Disease Mechanisms and Treatments
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.